Cargando…
Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema
PURPOSE: Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents reduces microaneurysms in patients with diabetic macular edema (DME). However, residual anti-VEGF-resistant telangiectatic capillaries (TelCaps) have been reported. In this study, we investigated changes in...
Autores principales: | Itou, Junichi, Furushima, Kei, Haruta, Masatoshi, Kato, Nobuhiro, Arai, Rikki, Mori, Kenichiro, Ishikawa, Keijiro, Yoshida, Shigeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869900/ https://www.ncbi.nlm.nih.gov/pubmed/36698851 http://dx.doi.org/10.2147/OPTH.S393360 |
Ejemplares similares
-
Decrease in Ocular Blood Flow Thirty Minutes After Intravitreal Injections of Brolucizumab and Aflibercept for Neovascular Age-Related Macular Degeneration
por: Kato, Nobuhiro, et al.
Publicado: (2023) -
Infrared reflectance image-guided laser photocoagulation of telangiectatic capillaries in persistent diabetic macular edema
por: Roh, Hyeon Cheol, et al.
Publicado: (2021) -
Changes in metamorphopsia after the treat-and-extend regimen of anti-VEGF therapy for macular edema associated with branch retinal vein occlusion
por: Mori, Kenichiro, et al.
Publicado: (2020) -
Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy
por: Matsuo, Yu, et al.
Publicado: (2021) -
Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients
por: Ishibashi, Koki, et al.
Publicado: (2021)